7151 N. Main St. Ste. 2 Clarkston, MI 48346
248-922-9610

Research

Investing in research, focused on patients

We invest in outstanding scientific research and innovative research models to expedite promising therapies to patients.
This is a pivotal time in the history of the amyloidosis, with the approval of three drugs for ATTR in 2019 and a number of new therapies on the horizon. Increasing the level of support is essential for research in these underserved diseases. Researchers, clinicians and partners in the biotech and pharmaceutical industries are working on the development of therapies that are changing the landscape and improving the outlook for patients.

The Amyloidosis Foundation is committed to serving patient needs by supporting research and providing annual grants for junior research scientists whose research targets the challenges in the field of amyloidosis.
For over a decade, the Amyloidosis Foundation grant program has supported outstanding research in all forms of systemic amyloidosis. Through our research program, we encourage, promote and invest in the medical study and exploration of amyloidosis diseases.

Research Grants

Candidates will have completed their doctoral studies or clinical fellowship within ten years prior to application. Grants are awarded for one year according to the award conditions and reporting guidelines.

On request, a second year of funding will be considered, pending a review of the research progress and as foundation funding permits.

Grant Programs
The foundation is dedicated to encouraging young scientists that show an interest in amyloidosis research, by providing travel grants to physicians and researchers who have completed their medical doctorate or fellowship within the past 10 years. These grants enable participation in the bi-annual International Amyloidosis Symposium.
2024 Junior Researcher Travel Award Application